CNBX Pharmaceuticals, Inc. (CNBX)
0.0001
0.00 (0.00%)
USD |
OTCM |
Sep 18, 16:00
CNBX Pharmaceuticals Cash from Investing (Quarterly) : 0.00 for May 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| May 31, 2026 | 0.00 |
| February 28, 2026 | 0.00 |
| November 30, 2025 | 0.00 |
| August 31, 2025 | 0.00 |
| May 31, 2025 | 0.00 |
| February 28, 2025 | 0.00 |
| November 30, 2024 | 0.00 |
| August 31, 2024 | 0.00 |
| May 31, 2024 | 0.0947M |
| February 29, 2024 | 0.02M |
| November 30, 2023 | -0.0012M |
| August 31, 2023 | 0.00 |
| May 31, 2023 | 0.00 |
| February 28, 2023 | 0.0247M |
| November 30, 2022 | 0.00 |
| August 31, 2022 | 0.0257M |
| May 31, 2022 | 0.00 |
| February 28, 2022 | 0.00 |
| November 30, 2021 | -0.0005M |
| August 31, 2021 | 0.00 |
| May 31, 2021 | 0.00 |
| February 28, 2021 | 0.646M |
| November 30, 2020 | -0.0009M |
| August 31, 2020 | 1.134M |
| May 31, 2020 | 0.3463M |
| Date | Value |
|---|---|
| February 29, 2020 | 0.9913M |
| November 30, 2019 | 0.815M |
| August 31, 2019 | 0.6412M |
| May 31, 2019 | -3.856M |
| February 28, 2019 | -0.7402M |
| November 30, 2018 | -1.296M |
| August 31, 2018 | -0.7003M |
| May 31, 2018 | -0.0983M |
| February 28, 2018 | -0.6394M |
| November 30, 2017 | -0.0045M |
| August 31, 2017 | -0.0347M |
| May 31, 2017 | -0.0893M |
| February 28, 2017 | -0.0017M |
| November 30, 2016 | 0.00 |
| August 31, 2016 | 0.00 |
| May 31, 2016 | 0.00 |
| February 29, 2016 | 0.00 |
| November 30, 2015 | 0.00 |
| August 31, 2015 | 0.0007M |
| May 31, 2015 | 0.00 |
| February 28, 2015 | 0.00 |
| November 30, 2014 | -0.0037M |
| August 31, 2014 | |
| May 31, 2014 | -0.03M |
| February 28, 2014 | 0.00 |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | 0.00 |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 54.90M |
| Fulcrum Therapeutics, Inc. | 13.78M |
| Definium Therapeutics, Inc. | -315.46M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -0.0477M |
| Cash from Financing (Quarterly) | 0.045M |
| Free Cash Flow | -0.1542M |
| Free Cash Flow to Equity (Quarterly) | -0.0495M |
| Free Cash Flow to Firm (Quarterly) | -0.0477M |
| Free Cash Flow Yield | -166.1% |